This is a summary of the European public assessment report (EPAR) for Zoely. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Zoely.
Therapeutic Indication
### Therapeutic indication Oral contraception
Therapeutic Area (MeSH)
N/AATC Code
G03AA14
ATC Item
nomegestrol and estradiol
Pharmacotherapeutic Group
Sex hormones and modulators of the genital system
Active Substance (Summary)
N/AINN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| Nomegestrol acetate | N/A | Nomegestrol acetate |
| estradiol | N/A | 雌二醇 |
EMA Name
Zoely
Medicine Name
Zoely
Aliases
N/ANo risk management plan link.
